Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days (Q43576750)

From Wikidata
Jump to navigation Jump to search
scientific article published in April 2001
edit
Language Label Description Also known as
English
Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days
scientific article published in April 2001

    Statements

    Phase I clinical and pharmacokinetic study of rebeccamycin analog NSC 655649 given daily for five consecutive days (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit